AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Another potential blockbuster just joined AbbVie's drug portfolio.

CryptoAlerta — análise de criptomoedas e mercado em tempo real